Keynote B15 - EV/Pembro vs GEM/CIS in muscle-invasive bladder cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
January 13, 2022
End Date
May 20, 2026
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
January 13, 2022
End Date
May 20, 2026